# Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors

> **NCT03424512** · NA · TERMINATED · sponsor: **University of Liverpool** · enrollment: 15 (actual)

## Conditions studied

- Cancer
- Anxiety
- Depression
- Quality of Life

## Interventions

- **BEHAVIORAL:** Group Metacognitive Therapy

## Key facts

- **NCT ID:** NCT03424512
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-01
- **Primary completion:** 2018-12-10
- **Final completion:** 2018-12-10
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Covid-19 halted study, reorganisation of the clincial service and staff leaving posts made recruitement to a group unfeasible
- **Last updated:** 2022-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424512, "Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03424512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*